
    
      Upon determination of eligibility, patients will receive:

      Induction Therapy

        -  Docetaxel

        -  Carboplatin

        -  5-FU

        -  Gefitinib

      Combined Modality Therapy

      Cohort 1:

        -  Radiation therapy

        -  Gefitinib

      Cohort 2:

        -  Radiation therapy

        -  Gefitinib

        -  Docetaxel
    
  